If you have been reading about Insulin-like growth factor 1 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
== Barium-131 == Barium-131 is a radioactive isotope of barium with a half-life of 11.52 days. It decays to caesium-131 by electron capture. It is produced by irradiation of caesium with protons with the reaction 133Cs(p,3n)131Ba. It is developed for SPECT imaging and can be combined with the alpha-emitter radium-223.
According to the Iraqi minutes from the meeting, examined in 2006 by the Parliamentary Commissioner for Standards Sir Philip Mawer and dismissed by Galloway as forgeries, Tariq Aziz, Naji Sabri and Saddam's personal secretary Abid Hamid Mahmud were in attendance as Galloway offered Saddam British staff to launch an English-language Iraqi satellite television channel, and said oil prices were having an impact on the income of the Mariam Appeal. In a radio interview given on the day following the discussion, Galloway said the Iraqi president was determined to show that his offer of readmitting the United Nations weapons inspectors into the country was sincere. Galloway said that the United States had nothing to lose by postponing its plans for invasion. In an 11 August article for The Mail on Sunday, Galloway wrote that Saddam "clearly understood that Iraq has to be seen to go the extra diplomatic mile" and that he expressed fondness for "everything quintessentially British". The piece was interpreted by the CNN as "the latest apparent charm offensive adopted by the Iraqi leader in the face of possible military action against it", and the British Foreign Office refused to consider the overtures. On 12 August, the Iraqi minister of information Muhammad Saeed al-Sahhaf rejected the return of the UN inspectors. In January 2003, Galloway met with Saddam Hussein and Tariq Aziz once more. His claim that the encounter was held in an underground bunker was later contradicted by the Iraqi president's interpreter.
In 2013, when a Salvadoran woman known as "Beatriz" was denied an abortion despite doctors saying that she would die in childbirth, Bukele called those who denied her an abortion "fanatics" ("fanáticos"). Bukele stated in October 2018 that he only supported abortion in cases where the mother's life was at risk, and expressed opposition to abortion on demand. Shortly after becoming president, he opposed abortion under any circumstances. In an interview with Puerto Rican rapper Residente, Bukele said that "someday, we are going to recognize that [abortion] is a great genocide" ("algún día, nos vamos a dar cuenta de que es un gran genocidio"). Bukele's August 2021 constitutional-reform proposal considered legalizing abortion in cases where the mother's life was at risk, adding that the proposal would have recognized the right to life for mother and child. He changed his mind the following month, saying that abortion would not be decriminalized and recognizing the "RIGHT TO LIFE (from the moment of conception)" of the unborn. Bukele also ruled out euthanasia.
=== September === September 1 Following reports of tensions with US Defense Secretary Pete Hegseth, US Army Secretary Daniel P. Driscoll steps down. The U.S. announces that it struck IRGC targets in Iran after the latter's attacks on commercial shipping in Hormuz and its soldiers, adding that it targeted tankers owned by the National Iranian Oil Company as part of its new "tanker to tanker" policy. Trump states that a most devastating attack is in the works, adding that when it is complete the Iranian government will be in ruins. Trump announces that a major target of those strikes were Iran's efforts to rebuild its radar system. Over $560,000 in cryptocurrency donations for Hamas are seized by the Justice Department. LGBTQ rights in the United States: The Department of Justice files a lawsuit against the Kansas City Public Schools district over its policies that allow transgender students to share their preferred name, gender, and pronouns with school staff. September 2 Birthright citizenship in the United States: American federal judge Deborah Boardman of the U.S. District Court for the District of Maryland blocks an attempt by the Trump administration to implement an executive order aimed at ending birthright citizenship in the United States. Hegseth extends the deployments of approximately 50,000 American soldiers in West Asia, which include warship crews, air defense units, and paratroopers, until 2027. September 3 Chipmaker Nvidia agrees to buy the Hugging Face AI platform in a deal worth $12.9 billion.
Hydrophilic/cytosolic – are soluble in water and are localized at the cytosol, including cAMP, cGMP, IP3, Ca2+, cADPR and S1P. Their main targets are protein kinases as PKA and PKG, being then involved in phosphorylation mediated responses. Hydrophobic/membrane-associated – are insoluble in water and membrane-associated, being localized at intermembrane spaces, where they can bind to membrane-associated effector proteins. Examples: PIP3, DAG, phosphatidic acid, arachidonic acid and ceramide. They are involved in regulation of kinases and phosphatases, G protein associated factors and transcriptional factors. Gaseous – can be widespread through cell membrane and cytosol, including nitric oxide and carbon monoxide. Both of them can activate cGMP and, besides of being capable of mediating independent activities, they also can operate in a coordinated mode.
Sources: en.wikipedia.org
== Use outside archaeology == Archaeology is not the only field that uses radiocarbon dating. Radiocarbon dates can also be used in geology, sedimentology, and lake studies, for example. The ability to date minute samples using AMS has meant that palaeobotanists and palaeoclimatologists can use radiocarbon dating directly on pollen purified from sediment sequences, or on small quantities of plant material or charcoal. Dates on organic material recovered from strata of interest can be used to correlate strata in different locations that appear to be similar on geological grounds. Dating material from one location gives date information about the other location, and the dates are also used to place strata in the overall geological timeline. Radiocarbon is also used to date carbon released from ecosystems, particularly to monitor the release of old carbon that was previously stored in soils as a result of human disturbance or climate change. Recent advances in field collection techniques also allow the radiocarbon dating of methane and carbon dioxide, which are important greenhouse gases.
Neutral Protamine Hagedorn (NPH) insulin, or isophane insulin, is an intermediate-acting insulin developed in 1946 to extend insulin activity through the addition of protamine, which slows absorption. It has an onset of about 90 minutes and lasts up to 24 hours, making it suitable for once- or twice-daily administration. NPH insulin is available as a recombinant human insulin and is sometimes premixed with short-acting insulin for combined basal and mealtime glucose control. During the 1980s, many individuals experienced difficulties when transitioning to intermediate-acting insulins, particularly NPH formulations of porcine and bovine insulins. These issues stemmed from variability in absorption and inconsistent glucose control. In response, basal insulin analogues were developed to provide a more stable and predictable absorption profile, leading to improved clinical efficacy and glycemic management.
=== Typical === Amino acid reuptake inhibitor Excitatory amino acid reuptake inhibitor (or glutamate-aspartate reuptake inhibitor) GABA reuptake inhibitor Glycine reuptake inhibitor Monoamine reuptake inhibitor Dopamine reuptake inhibitor Norepinephrine reuptake inhibitor Serotonin reuptake inhibitor Serotonin-norepinephrine reuptake inhibitor Norepinephrine-dopamine reuptake inhibitor Serotonin-dopamine reuptake inhibitor Serotonin-norepinephrine-dopamine reuptake inhibitor Miscellaneous Adenosine reuptake inhibitor Endocannabinoid reuptake inhibitor
=== Methylglycinediacetic acid (MGDA) === Trisodium dicarboxymethyl alaninate, also known as methylglycinediacetic acid (MGDA), has a high rate of biodegradation at over 68%, but unlike many other chelating agents can degrade without the assistance of adapted bacteria. Additionally, unlike EDDS or IDS, MGDA can withstand higher temperatures while maintaining a high stability as well as the entire pH range. MGDA has been shown to be an effective chelating agent, with a capacity for mobilization comparable with that of nitrilotriacetic acid (NTA), with application to water for industrial use and for the removal of calcium oxalate from urine from patients with kidney stones.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
It mimics a natural hypothalamic signal that tells the pituitary to release growth hormone. The result is a rise in circulating growth hormone and, indirectly, in insulin-like growth factor 1. Over weeks of treatment this shift is associated with a selective decrease in fat stored inside the abdomen.